New users of SGLT2 inhibitors were compared with new users of GLP-1 receptor agonists in type 2 diabetes with stage III to IV kidney disease. A scan of all diagnosis codes in 22,328 Medicare and 8,918 commercial matched pairs detected genital infections in both sexes, and nothing else. No signal appeared in inpatient or emergency department codes.
Why it is interesting: An untargeted screen of every diagnosis code tests a class in patients often underrepresented in trials.
Cite this item
BibTeX
Free sign-up. A digest of the new papers twice a week, grouped by domain.